2022 Health Technology Pharmaceuticals 
Health Populi
OCTOBER 6, 2021
The Consumer Technology Association (CTA) announced that Robert Ford, CEO and President of Abbott, will give a keynote speech at CES 2022, the world’s largest annual convention of the technology industry. The post Why CES 2022 Will Be Keynoted by a Health Care Executive appeared first on HealthPopuli.com.
Digital Health Global
OCTOBER 23, 2023
CRNSV”) was formed by former executives and directors of Nymox Pharmaceutical Corporation (“Nymox” or the “Company”), who were improperly removed from their positions, with a goal to recover shareholder value in Nymox. Additionally, from just January 1, 2021 to December 31, 2022, he paid himself over $1,400,000 in Company cash.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
DECEMBER 27, 2021
In October 2021, the Consumer Technology Association (CTA) announced that Robert Ford, CEO and President of Abbott, would give a keynote speech at CES 2022, the world’s largest annual convention of the technology industry.
Digital Health Global
JANUARY 22, 2024
“West Penn was among the first hospitals where we launched ActivSight in 2022,” said Manisha Shah-Bugaj, Chief Executive Officer at Activ Surgical. Hikma Ventures led Activ Surgical’s Series B extension round in March 2022 and has made 20 investments to date in global digital health companies.
Digital Health Global
SEPTEMBER 28, 2023
growth in revenue in 2023, having delivered 2022 revenues of nearly $2.0 from 2020 to 2022, reaching $327.3 Life sciences companies are also high-impact job creators, with surveyed companies forecasting nearly 6,000 employees in 2023 — up 1,800 (44.3%) from 2022. million in 2022 from nearly $1.4 million last year.
Lloyd Price
NOVEMBER 25, 2023
These multiples are down from the levels seen in 2022, but they are still higher than the average EV to sales multiple for all industries. Here are some additional insights into DTx M&A deals in 2023: The most active acquirers in the DTx M&A market are pharmaceutical companies, followed by technology companies.
Digital Health Global
APRIL 5, 2024
The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity.
Expert insights. Personalized for you.
367 
Let's personalize your content